SCHEMBL22268222

SCHEMBL22268222

C/C=C1\COCCN1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13501652 0.71 — —
SCHEMBL1698642 0.71 PIK3CD (0.37) —
SCHEMBL20936293 0.68 — —
SCHEMBL22268216 0.64 — —
SCHEMBL19754397 0.63 ACHE (0.38) —
SCHEMBL24728918 0.62 — —
SCHEMBL25081718 0.62 — —
SCHEMBL22648379 0.61 PIK3CD (0.36) —
SCHEMBL13684170 0.61 PIK3CD (0.39) —
SCHEMBL10312571 0.60 PIK3CD (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723733-B2 Hepatitis B antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2020-07-28 — — US disclosed
Send feedback